| Literature DB >> 24708588 |
Issakou Bakarnga-Via, Jean Baptiste Hzounda, Patrick Valere Tsouh Fokou, Lauve Rachel Yamthe Tchokouaha, Magali Gary-Bobo, Audrey Gallud, Marcel Garcia, Lucain Walbadet, Youssouf Secka, Pierre Michel Jazet Dongmo, Fabrice Fekam Boyom1, Chantal Menut.
Abstract
BACKGROUND: Cancer has become a global public health problem and the search for new control measures is urgent. Investigation of plant products such as essential oils from Monodora myristica, Xylopia aethiopica and Xylopia parviflora might lead to new anticancer therapy. In this study, we have investigated the antineoplastic activity of essential oils from fruits of these plants growing in Chad and Cameroon.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24708588 PMCID: PMC4020318 DOI: 10.1186/1472-6882-14-125
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Relative percentages of constituents of essential oils from fruits of , and
| | Chad | CMR | Chad | CMR | Chad | CMR | | |
| | ||||||||
| | ||||||||
| α-thujene | 1.3 | 1.0 | - | - | 2.4 | 1.4 | LRI. GCMS | |
| α-pinene | 8.3 | 10.8 | 11.1 | 10.8 | 6.7 | 4.2 | LRI. GCMS | |
| sabinene | 14.5 | 4.8 | 3.2 | 3.0 | 0.3 | 0.1 | LRI. GCMS | |
| β-pinene | 24.6 | 28.2 | 35.7 | 32.9 | 0.5 | 0.3 | LRI. GCMS | |
| myrcene | 0.3 | 0.3 | - | - | 5.1 | 3.8 | LRI. GCMS | |
| α-phellandrene | 0.6 | 0.5 | - | - | 52.7 | 67.1 | LRI. GCMS | |
| α-terpinene | 2.8 | 3.4 | - | - | 0.2 | 0.1 | LRI. GCMS | |
| p-cymene | 0.6 | 0.8 | 1.2 | 2.8 | tr | tr | LRI. GCMS | |
| limonene | 1.7 | 0.4 | 0.3 | 0.5 | 14.9 | 1.8 | LRI. GCMS | |
| β-phellandrene | 10.4 | 5.8 | 0.6 | 0.7 | 4.2 | 3.0 | LRI. GCMS | |
| 1,8-cineole | - | - | 1.0 | 2.0 | - | LRI. GCMS | ||
| ( | 1.1 | 1.3 | tr | Tr | 0.3 | 0.3 | LRI. GCMS | |
| ( | 0.2 | 1.3 | 5.4 | 8.0 | 0.1 | 0.2 | LRI. GCMS | |
| γ-terpinene | 4.9 | 5.7 | - | - | 0.4 | tr | LRI. GCMS | |
| terpinolene | 1.1 | 1.5 | - | - | tr | tr | LRI. GCMS | |
| | ||||||||
| 0.4 | 0.3 | - | - | LRI. GCMS | ||||
| linalool | - | - | 0.6 | 0.7 | 2.4 | 2.1 | LRI. GCMS | |
| 0.3 | 0.3 | - | - | 0.2 | tr | LRI. GCMS | ||
| - | - | - | - | 0.1 | tr | LRI. GCMS | ||
| 0.6 | 0.9 | 4.0 | 3.2 | LRI. GCMS | ||||
| - | - | 0.7 | 0.4 | LRI. GCMS | ||||
| pinocarvone | - | - | 1.2 | 0.7 | LRI. GCMS | |||
| borneol | - | - | 0.6 | 0.6 | LRI. GCMS | |||
| terpinen-4-ol | 10.0 | 15.1 | 0.8 | 0.7 | LRI. GCMS | |||
| p-cymen-8-ol | - | - | 1.0 | 0.7 | - | - | LRI. GCMS | |
| α-terpineol | 1.6 | 3.6 | 1.4 | 1.7 | 0.5 | 0.6 | LRI. GCMS | |
| myrtenol | - | - | 6.5 | 5.2 | LRI. GCMS | |||
| mytenal | 0.4 | 1.4 | - | - | LRI. GCMS | |||
| - | - | - | - | 2.8 | 0.7 | LRI. GCMS | ||
| - | - | 0.1 | - | LRI. GCMS | ||||
| bornyl acetate | - | - | 0.6 | 0.4 | LRI. GCMS | |||
| thymol | - | - | 0.3 | - | LRI. GCMS | |||
| | ||||||||
| | ||||||||
| δ-elemene | 0.9 | 0.8 | tr | Tr | LRI. GCMS | |||
| α-cubebene | 0.2 | 0.4 | tr | Tr | LRI. GCMS | |||
| α-ylangene | 0.8 | 0.4 | 0.4 | 0.6 | LRI. GCMS | |||
| α-copaene | tr | tr | 0.4 | 0.5 | LRI. GCMS | |||
| β-elemene | 0.4 | 0.5 | 0.6 | 0.4 | 0.1 | 0.1 | LRI. GCMS | |
| β-caryophyllene | 0.3 | tr | tr | Tr | 0.2 | 0.3 | LRI. GCMS | |
| β-copaene | - | - | 1.4 | 1.1 | - | - | | |
| α-humulene | 0.2 | 0.8 | 0.1 | 0.3 | LRI. GCMS | |||
| γ-muurolene | 0.4 | 1.1 | 0.3 | 0.5 | 0.1 | 0.4 | LRI. GCMS | |
| germacrene D | 7.2 | 5.1 | 1.3 | 2.0 | LRI. GCMS | |||
| - | - | 1.6 | 1.8 | 0.4 | 0.3 | LRI. GCMS | ||
| bicyclogermacrene | 0.5 | 0.3 | 0.1 | - | LRI. GCMS | |||
| α-muurolene | - | - | 0.7 | 0.8 | 0.1 | 0.4 | LRI. GCMS | |
| γ-cadinene | - | - | 0.1 | 1.7 | LRI. GCMS | |||
| δ-cadinene | 0.7 | 0.3 | 3.6 | 3.7 | 0.7 | 3.2 | LRI. GCMS | |
| germacrene B | 0.4 | 0.5 | LRI. GCMS | |||||
| | ||||||||
| cubebol | - | - | 1.5 | 1.7 | - | - | LRI. GCMS | |
| elemol | - | - | 1.5 | 2.0 | - | LRI. GCMS | ||
| germacrene D-4-ol | - | - | 0.5 | 1.3 | LRI. GCMS | |||
| caryophyllene oxide | - | - | 3.0 | 2.0 | LRI. GCMS | |||
| M = 220 | 0.3 | 1.1 | 1.0 | 0.8 | GCMS | |||
| - | - | 2.0 | 2.4 | 0.1 | 0.9 | LRI. GCMS | ||
| α-muurolol | - | - | 2.0 | 2.9 | LRI. GCMS | |||
| α-cadinol | 0.3 | 0.3 | 0.1 | 0.9 | LRI. GCMS | |||
| germacra-4(15),5, 10(14)-triene-1- α-ol | - | - | 1.8 | 1.5 | - | - | LRI. GCMS | |
| shyobunol | - | - | 0.7 | 0.3 | LRI. GCMS | |||
| ( | - | - | - | 1.1 | LRI. GCMS | |||
| | ||||||||
CMR = Cameroon; LRI = linear retention indices on a HP-5 column; - = not found, tr = trace (relative concentration < 0.1%); EO = essential oil.
Figure 1Dose-dependent cytotoxic effect of the essential oils of X. parviflora from Chad (A) and Cameroon (B), X. aethiopica from Chad (C) and Cameroon (D) and M. myristica from Chad (E) and Cameroon (F). Human breast cancer (MCF-7) and normal (ARPE-19) cell lines were incubated 72 h with increasing doses of essential oils from 0.1 to 2 μL/mL. After treatment, cytotoxicity was measured by MTT assay as described in Material and Methods. Values are means ± standard deviations of three independent experiments.